Mycobacterium tuberculosis exploits the formation of new blood vessels for its dissemination-Reference-Cited by-同舟云学术

Mycobacterium tuberculosis exploits the formation of new blood vessels for its dissemination

Published:2016-09-12 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Polena Helena,Boudou Frédéric,Tilleul Sylvain,Dubois-Colas Nicolas,Lecointe Cécile,Rakotosamimanana Niaina,Pelizzola Mattia,Andriamandimby Soa Fy,Raharimanga Vaomalala,Charles Patricia,Herrmann Jean-Louis,Ricciardi-Castagnoli Paola,Rasolofo Voahangy,Gicquel Brigitte,Tailleux Ludovic

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep33162.pdf

Reference62 articles.

1. Zumla, A. et al. The WHO 2014 global tuberculosis report–further to go. Lancet Glob Health 3, e10–e12 (2015).

2. Russell, D. G., Cardona, P. J., Kim, M. J., Allain, S. & Altare, F. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat Immunol 10, 943–948 (2009).

3. Tsai, M. C. et al. Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell Microbiol 8, 218–232 (2006).

4. Ulrichs, T. & Kaufmann, S. H. New insights into the function of granulomas in human tuberculosis. J Pathol 208, 261–269 (2006).

5. Djoba Siawaya, J. F. et al. Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis. Cytokine 47, 132–136 (2009).

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Host urinary biomarkers in HIV positive and HIV negative patients with tubercular uveitis and other uveitic diseases;Tuberculosis;2024-09

2. P-glycoprotein inhibitors as an adjunct therapy for TB;Drug Discovery Today;2024-09

3. Leveraging insights from cancer to improve tuberculosis therapy;Trends in Molecular Medicine;2024-08

4. Neutrophil extracellular traps characterize caseating granulomas;Cell Death & Disease;2024-07-31

5. Impact of the diseased lung microenvironment on the in vivo fate of inhaled particles;Drug Discovery Today;2024-07